A review on the therapeutic potential of embryonic and induced pluripotent stem cells in hepatic repair

Journal of Natural Science, Biology and Medicine

Volumn 2, Issue 2, 2011, Pages 141-144

  Ananda Krishna, K ^a   Sai Krishna, K ^b   Berrocal, Ruben ^c   Tummala, Alekya ^d   Rao, K S ^c   Sambasiva Rao, K R S ^a,c  

^a ACHARYA NAGARJUNA UNIVERSITY   (India)

^b Meenakshi Medical College and Research Institute   (India)

^c Tecnología e innovación   (Panama)

^d Department of Clinical Biochemistry   (Panama)

Author keywords

Embryonic stem cells; End stage liver disease; Hepatocytes; Induced pluripotent stem cells; Liver; Stem cells

Indexed keywords

EID: 84878685514     PISSN: 09769668     EISSN: 22297707     Source Type: Journal    
DOI: 10.4103/0976-9668.92314     Document Type: Review

References (41)

1. Weisberg IS, Brown RS Jr, Sigal SH. Hepatitis B and end-stage liver disease. Clin Liver Dis 2007;11:893-916.
2. Centres for Disease Control and Prevention. Monthly vital statistics report. Available from: http://www.cdc.gov/nchs/hus.htm. [cited in 2010].
3. Lorenzini S, Gitto S, Grandini E, Andreone P, Bernardi M. Stem cells for end stage liver disease: how far have we got? World J Gastroenterol 2008;14:4593-9.
4. Feldmann G. Liver transplantation of hepatic stem cells: Potential use for treating liver diseases. Cell Biol Toxicol 2001;17:77-85.
5. Flohr TR, Bonatti H Jr, Brayman KL, Pruett TL. The use of stem cells in liver disease. Curr Opin Organ Transplant 2009;14:64-71.
6. Ogawa S, Miyagawa S. Potentials of regenerative medicine for liver disease. Surg Today 2009;39:1019-25.
7. Lorenzini S, Gitto S, Grandini E, Andreone P, Bernardi M. Stem cells for end stage liver disease: How far have we got? World J Gastroenterol 2008;14:4593-9.
8. Cantz T, Manns MP, Ott M. Stem cells in liver regeneration and therapy. Cell Tissue Res 2008;331:271-82.
9. Cantz T, Manns MP, Ott M. Stem cells in liver regeneration and therapy. Cell Tissue Res 2008;331:271-82
10. Lysy PA, Campard D, Smets F, Najimi M, Sokal EM. Stem cells for liver tissue repair: current knowledge and perspectives. World J Gastroenterol 2008;14:864-75.
11. Allen KJ, Buck NE, Williamson R. Stem cells for the treatment of liver disease. Transpl Immunol 2005;15:99-112.
12. Asgari S, Pournasr B, Salekdeh GH, Ghodsizadeh A, Ott M, Baharvand H. Induced pluripotent stem cells: A new era for hepatology. Hepatol 2010;53:738-51.
13. Liu SP, Fu RH, Huang YC, Chen SY, Chien YJ, Hsu CY, et al. Induced Pluripotent Stem (iPS) cell research overview. Cell Transplant 2011;20:15-9
14. Liu T, Wang Y, Tai G, Zhang S. Could co-transplantation of iPS cells derived hepatocytes and MSCs cure end-stage liver disease? Cell Biol Int 2009;33:1180-3.
15. Sullivan GJ, Hay DC, Park IH, Fletcher J, Hannoun Z, Payne CM, et al. Generation of functional human hepatic endoderm from human induced pluripotent stem cells. Hepatology 2010;51:329-35.
16. Schwartz RE, Linehan JL, Painschab MS, Hu WS, Verfaillie CM, Kaufman DS. Defined conditions for development of functional hepatic cells from human embryonic stem cells. Stem Cells Dev 2005;14:643-55.
17. Feldmann G. Liver transplantation of hepatic stem cells: Potential use for treating liver diseases. Cell Biol Toxicol 2001;17:77-85.
18. Mitaka T. Hepatic stem cells: From bone marrow cells to hepatocytes. Biochem Biophys Res Commun 2001;281:1-5.
19. Vessey CJ, de la Hall PM. Hepatic stem cells: A review. Pathology 2001;33:130-41.
20. Forbes S, Vig P, Poulsom R, Thomas H, Alison M. Hepatic stem cells. J Pathol 2002;197:510-8.
21. am Esch JS 2nd, Knoefel WT, Klein M, Ghodsizad A, Fuerst G, Poll LW, et al. Portal application of autologous CD133+ bone marrow cells to the liver: a novel concept to support hepatic regeneration. Stem Cells 2005;23:463-70.
22. Gordon MY, Levicar N, Pai M, Bachellier P, Dimarakis I, Al-Allaf F, et al. Characterization and clinical application of human CD34+ stem/ progenitor cell populations mobilized into the blood by granulocyte colony-stimulating factor. Stem Cells 2006;24:1822-30.
23. Terai S, Ishikawa T, Omori K, Aoyama K, Marumoto Y, Urata Y, et al. Improved liver function in patients with liver cirrhosis after autologous bone marrow cell infusion therapy. Stem Cells 2006;24:2292-8.
24. Mohamadnejad M, Namiri M, Bagheri M, Hashemi SM, Ghanaati H, Zare Mehrjardi N, et al. Phase 1 human trial of autologous bone marrow-hematopoietic stem cell transplantation in patients with decompensated cirrhosis. World J Gastroenterol 2007;13:3359-63.
25. Mohamadnejad M, Alimoghaddam K, Mohyeddin-Bonab M, Bagheri M, Bashtar M, Ghanaati H, et al. Phase 1 trial of autologous bone marrow mesenchymal stem cell transplantation in patients with decompensated liver cirrhosis. Arch Iran Med 2007;10:459-66.
26. Forbes SJ, Poulsom R, Wright NA. Hepatic and renal differentiation from blood-borne stem cells. Gene Ther 2002;9:625-30.
27. Forbes SJ, Vig P, Poulsom R, Alison MR, Wright NA. Bone marrowderived liver stem cells: Their therapeutic potential. Gastroenterology 2002;123:654-5.
28. Grompe M. The role of bone marrow stem cells in liver regeneration. Semin Liver Dis 2003;23:363-72.
29. De Silvestro G, Vicarioto M, Donadel C, Menegazzo M, Marson P, Corsini A. Mobilization of peripheral blood hematopoietic stem cells following liver resection surgery. Hepatogastroenterology 2004;51:805-10.
30. Lee KD, Kuo TK, Whang-Peng J, Chung YF, Lin CT, Chou SH, et al. In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology 2004;40:1275-84.
31. Götherström C, West A, Liden J, Uzunel M, Lahesmaa R, Le Blanc K. Difference in gene expression between human fetal liver and adult bone marrow mesenchymal stem cells. Haematologica 2005;90: 1017-26.
32. Lemoli RM, Catani L, Talarico S, Loggi E, Gramenzi A, Baccarani U, et al. Mobilization of bone marrow-derived hematopoietic and endothelial stem cells after orthotopic liver transplantation and liver resection. Stem Cells 2006;24:2817-25.
33. Taléns-Visconti R, Bonora A, Jover R, Mirabet V, Carbonell F, Castell JV, et al. Human mesenchymal stem cells from adipose tissue: Differentiation into hepatic lineage. Toxicol In Vitro 2007;21:324-9.
34. Fürst G, Schulte am Esch J, Poll LW, Hosch SB, Fritz LB, Klein M, et al. Portal vein embolization and autologous CD133+ bone marrow stem cells for liver regeneration: Initial experience. Radiology 2007;243:171-9.
35. Cai J, Zhao Y, Liu Y, Ye F, Song Z, Qin H, et al. Directed differentiation of human embryonic stem cells into functional hepatic cells. Hepatology 2007;45:1229-39.
36. Campard D, Lysy PA, Najimi M, Sokal EM. Native umbilical cord matrix stem cells express hepatic markers and differentiate into hepatocyte-like cells. Gastroenterology 2008;134:833-48.
37. Kuo TK, Hung SP, Chuang CH, Chen CT, Shih YR, Fang SC, et al. Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells. Gastroenterology 2008;134:2111-21,2121.e1-3.
38. Banas A, Teratani T, Yamamoto Y, Tokuhara M, Takeshita F, Osaki M, et al. Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure. J Gastroenterol Hepatol 2009;24:70-7.
39. Yagi H, Tafaleng E, Nagaya M, Hansel MC, Strom SC, Fox IJ, et al. Embryonic and induced pluripotent stem cells as a model for liver disease. Crit Rev Biomed Eng 2009;37:377-98.
40. Chang YJ, Liu JW, Lin PC, Sun LY, Peng CW, Luo GH, et al. Mesenchymal stem cells facilitate recovery from chemically induced liver damage and decrease liver fibrosis. Life Sci 2009;85:517-25.
41. Song Z, Cai J, Liu Y, Zhao D, Yong J, Duo S, et al. Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells. Cell Res 2009;19:1233-42.